Discovery of HN37 as a Potent and Chemically Stable Antiepileptic Drug Candidate
Open accessThe DOI matches its Crossref record; 2 of the 2 references it cites were found in a registry or an index.
Abstract
We previously reported that P-retigabine (P-RTG), a retigabine (RTG) analogue bearing a propargyl group at the nitrogen atom in the linker of RTG, displayed moderate anticonvulsant efficacy. Recently, our further efforts led to the discovery of HN37 (pynegabine), which demonstrated satisfactory chemical stability upon deleting the ortho liable −NH 2 group and installing two adjacent methyl groups to the carbamate motif. HN37 exhibited enhanced activation potency toward neuronal Kv7 channels and high in vivo efficacy in a range of pre-clinical seizure models, including the maximal electroshock test and a 6 Hz model of pharmacoresistant limbic seizures. With its improved chemical stability, strong efficacy, and better safety margin, HN37 has progressed to clinical trial in China for epilepsy treatment.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Shapiro, M. S., Roche, J. P., Kaftan, E. J., Cruzblanca, H., Mackie, K., & Hille, B. (2000) · The Journal of Neuroscience · doi:10.1523/jneurosci.20-05-01710.2000 · Cited by 201
Modulation of Kv7 channels and excitability in the brain
Greene, D. L., & Hoshi, N. (2017) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-016-2359-y · Cited by 177
Cited by
Musella, S., Carotenuto, L., Iraci, N., Baroli, G., Ciaglia, T., Nappi, P., Basilicata, M. G., Salviati, E., Barrese, V., Vestuto, V., et al. (2022) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.2c00911 · Cited by 45
Targeting Kv7 Potassium Channels for Epilepsy
Perucca, E., & Taglialatela, M. (2025) · CNS Drugs · doi:10.1007/s40263-024-01155-3 · Cited by 43
“7) is an ezogabine derivative developed at the Shanghai Institute of Materia Medica [165, 166].”
InfluentialWang, H., Qiao, Z., Luan, K., Xiang, W., Chang, X., Zhang, Y., Wei, N., & Wang, K. (2024) · Epilepsia · doi:10.1111/epi.18092 · Cited by 16
Self-citationHernandez, C. C., Tarfa, R. A., Miguel I. Limcaoco, J., Liu, R., Mondal, P., Hill, C., Duncan, K. R., Tzounopoulos, T., Stephenson, C. R. J., O'Meara, M. J., et al. (2022) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2022.128841 · Cited by 11
Carotenuto, L., Keminer, O., Carleo, G., Zaliani, A., Leo, A., Citraro, R., De Sarro, G., Dirkx, N., Kaji, M., Weckhuysen, S., et al. (2025) · British Journal of Pharmacology · doi:10.1111/bph.70119 · Cited by 10
“3 activators effectively counteracted PTZ-induced seizures (Bloms-Funke et al., 2022; Grupe et al., 2020; Zhang et al., 2021) or sound-induced seizures in DBA/2 mice (Bloms-Funke et al., 2022), thus confirming the validity of these two animal models for evaluating the anticonvulsant efficacy of Kv7…”
Metadata
- Authors
- Zhang, Y.-M., Xu, H.-Y., Hu, H.-N., Tian, F.-Y., Chen, F., Liu, H.-N., Zhan, L., Pi, X.-P., Liu, J., Gao, Z.-B., & Nan, F.-J.
- Venue
- Journal of Medicinal Chemistry
- Publisher
- American Chemical Society (ACS)
- Published
- 2021-04-30
- Volume
- 64
- Issue
- 9
- Pages
- 5816-5837
- ISSN
- 0022-2623 (ISSN-L)
- 1520-4804
- OpenAlex
- W3158803573
- Cited by
- 49
- References
- 2
- FWCI
- 4.44
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Discovery of HN37 as a Potent and Chemically Stable Antiepileptic Drug Candidate. https://app.cochat.ai/papers/10.1021/acs.jmedchem.0c02252
- The paper
- Zhang, Y.-M., Xu, H.-Y., Hu, H.-N., Tian, F.-Y., Chen, F., Liu, H.-N., Zhan, L., Pi, X.-P., Liu, J., Gao, Z.-B., & Nan, F.-J. (2021). Discovery of HN37 as a Potent and Chemically Stable Antiepileptic Drug Candidate. Journal of Medicinal Chemistry. https://doi.org/10.1021/acs.jmedchem.0c02252
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.